Suryoday Small Finance Bank’s record carries five years of unqualified audit opinions and no reported fraud, but the governance structure around its promoter MD & CEO is unusually opaque. The Bank invokes an RBI exemption to avoid disclosing any transactions with him and his relatives, even as shareholders are asked to approve a personal financing deal that pledges promoter shares and shares equity upside. RBI penalties have escalated from minor fines to a ₹57.75 lakh fraud-reporting penalty, and operating cash flow has swung from deep negative to strongly positive, yet the bank resumed dividends only recently.
Key findings
- RBI penalties escalated from minor operational fines to a ₹57.75 lakh fraud-reporting penalty, followed by a ₹2 lakh SGL bouncing penalty in FY26
Major- In FY2022-23, RBI imposed a monetary penalty of ₹57.75 lakh for delayed reporting of frauds and failure to report fraud complaints to police authorities under the RBI (Frauds classification and reporting) Directions 2016. This followed a ₹0.03 crore penalty in FY2020-21 for delay in filing FCGPR for FDI, and was succeeded by a ₹10,000 penalty in FY2023-24 for not extending exchange facilities for soiled notes and a ₹2,00,000 penalty for SGL bouncing, communicated on July 29, 2025. - Operating cash flow has swung from deep negative to strongly positive, yet the bank resumed dividends only recently
Minor- CFO was negative ₹876 Cr in FY21, negative ₹347 Cr in FY22, and negative ₹97.70 Cr in FY23, then turned positive to ₹935 Cr in FY24, ₹1,320 Cr in FY25, and ₹652 Cr in FY26. PAT was ₹11.86 Cr in FY21, negative ₹93.03 Cr in FY22, ₹77.69 Cr in FY23, ₹216 Cr in FY24, ₹115 Cr in FY25, and ₹152 Cr in FY26. The Board recommended a final dividend of ₹1.50 per equity share for FY26, after paying no dividend in FY21 and FY22 and recommending no dividend in FY24 and FY25.
What to watch
- MD & CEO and Executive Director remuneration vote. The 18th AGM notice dated July 14, 2026, seeks approval for MD & CEO remuneration of ₹2.50 crore p.a. and Executive Director remuneration of ₹1.90 crore p.a. for FY2026-27, along with ESOP Scheme 2019 amendments extending the exercise period to 5 years.
- Dividend approval. Shareholder approval for the ₹1.50 per share final dividend is scheduled at the 18th AGM on August 06, 2026.
- Variable pay awaiting RBI approval. RBI approval is awaited for variable remuneration of ₹1.75 crore for the MD & CEO and ₹75 lakh for the Executive Director for FY2025-26, and for the Executive Director’s revised fixed remuneration for FY2026-27.
- Investor Director term expiry. Mr. Ranjit Jayant Shah’s term as Investor Director expires November 1, 2026, upon completion of 8 years under the BR Act.
- Promoter financing agreement remains in effect. The financing agreement between Mr. Baskar Babu Ramachandran and Placid Limited remains in effect with 3,140,000 promoter shares pledged; any sale of those shares would trigger the equity upside distribution mechanism described in the FY2020-21 AGM notice.
Bottom line: This is a disclosed and audited banking record with five years of clean audit opinions and no reported fraud. The risk sits in governance opacity: the Bank withholds related-party disclosures under an RBI exemption while the promoter MD & CEO’s personal financing deal pledges promoter shares and shares equity upside with a lender. Read the related-party note with that gap in mind, and watch the AGM votes on remuneration and the expiry of the investor director’s term.